Discovering and Developing Novel, Neurological and Metabolic Therapeutics
At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated agents addressing neurological and metabolic diseases.
Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are using our Klarity Platform to investigate medicines in metabolism, leading with type 2 diabetes and obesity, and neurological disorders, including migraine and pain.
Our Science
We are pursuing novel approaches to discovering medicines for neurological and metabolic diseases.
